Gene · 6439
Papers3,679
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,679
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSF2RB mutation-related hereditary pulmonary alveolar proteinosis: the "long and winding road" into adulthood. | ERJ Open Res | 2023 | 38111540 | PubTator, text mining | PubMed |
| A new measure of node centrality on schedule-based space-time networks for the designation of spread potential. | Sci Rep | 2023 | 38110451 | PubTator, text mining | PubMed |
| Pressure-support compared with pressure-controlled ventilation mitigates lung and brain injury in experimental acute ischemic stroke in rats. | Intensive Care Med Exp | 2023 | 38102452 | PubTator, text mining | PubMed |
| COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes. | Commun Biol | 2023 | 38092883 | PubTator, text mining | PubMed |
| Bw4 ligand and direct T-cell receptor binding induced selection on HLA A and B alleles. | Front Immunol | 2023 | 38077375 | PubTator, text mining | PubMed |
| New Insights via RNA Profiling of Formalin-Fixed Paraffin-Embedded Lung Tissue of Pulmonary Fibrosis Patients. | Int J Mol Sci | 2023 | 38069069 | PubTator, text mining | PubMed |
| CC16 drives VLA-2-dependent SPLUNC1 expression. | Front Immunol | 2023 | 38053993 | PubTator, text mining | PubMed |
| Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. | Front Pharmacol | 2023 | 38044943 | PubTator, text mining | PubMed |
| Towards personalized therapies for genetic disorders of surfactant dysfunction. | Semin Fetal Neonatal Med | 2023 | 38036307 | PubTator, text mining | PubMed |
| Characterization of a unique repression system present in arbitrium phages of the SPbeta family. | Cell Host Microbe | 2023 | 38035880 | PubTator, text mining | PubMed |
| Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery. | Front Pharmacol | 2023 | 38026982 | PubTator, text mining | PubMed |
| Human pluripotent stem cell fate trajectories toward lung and hepatocyte progenitors. | iScience | 2023 | 38026193 | PubTator, text mining | PubMed |
| Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment. | Front Immunol | 2023 | 38022613 | PubTator, text mining | PubMed |
| A Case Report of Plasmacytoma in a 28-Year-Old Patient: Bridging the Age Gap in a Rare Presentation. | Cureus | 2023 | 38022027 | PubTator, text mining | PubMed |
| Lung transplantation outcome in adult surfactant-related interstitial lung disease: first evidence to move on. | ERJ Open Res | 2023 | 38020569 | PubTator, text mining | PubMed |
| Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis-A Systematic Review. | J Pers Med | 2023 | 38003922 | PubTator, text mining | PubMed |
| Alveolar Type 2 Epithelial Cell Organoids: Focus on Culture Methods. | Biomedicines | 2023 | 38002035 | PubTator, text mining | PubMed |
| Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma. | BMC Cancer | 2023 | 38001428 | PubTator, text mining | PubMed |
| Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells. | Metabolites | 2023 | 37999228 | PubTator, text mining | PubMed |
| Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single-Cell Transcriptomics. | Adv Sci (Weinh) | 2023 | 37991139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6439/papers?page=11